首页> 外文期刊>Journal of Probiotics & Health >The i-screen A Versatile Preclinical Platform for Gut Microbiota Studies
【24h】

The i-screen A Versatile Preclinical Platform for Gut Microbiota Studies

机译:I-屏幕是肠道微生物群研究的多功能临床前平台

获取原文
       

摘要

The gut microbiota is the complex community of microorganisms that inhabit the human intestine. Gut microbes participate in many aspects of human physiology, including health and disease. Food ingredients, drugs and other environmental factors can affect the gut microbiota, with possible consequences on human health.Progress in microbiome research has significantly stimulated and expanded the interest in technologies to study the potential of different products to modulate the gastro-intestinal ecosystem. In this context we have developed a method, called the i-screen, to evaluate the effects of compounds on the human gut microbiota. The i-screen is an in vitro system that allows the anaerobic cultivation of microorganisms obtained from fecal material, and therefore representative of the highly diverse colonic microbiota. By means of specific analyses, the effects of test compounds on the gut microbiota composition and metabolic activity can be assessed.The i-screen has proven to be an effective and versatile experimental model of the gut microbiota, routinely applied to evaluate the effects of food ingredients and drugs. This system constitutes a valid contribution to product development and a starting point for a better understanding of the role of gut microbiota in host health.
机译:肠道微生物群是居住人肠的复杂的微生物群落。肠微生物参与人体生理学的许多方面,包括健康和疾病。食品成分,药物和其他环境因素可以影响肠道微生物群,对人体健康的可能后果。微生物组研究中的方法显着刺激和扩大了研究不同产品的潜力来调节胃肠生态系统的潜力。在这种情况下,我们开发了一种称为I型屏幕的方法,评估化合物对人体肠道微生物群的影响。 I-屏幕是一种体外系统,允许厌氧培养从粪便材料获得的微生物培养,因此代表高度多样化的结肠微生物。通过具体的分析,可以评估测试化合物对肠道微生物酵母组合物和代谢活性的影响。I-筛网已被证明是肠道微生物群的有效和通畅性的实验模型,常规应用于评估食物的影响成分和药物。该系统构成了对产品开发的有效贡献和更好地理解肠道微生物群在宿主健康中的作用的起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号